Key Highlights

  • Clarivate (NYSE:CLVT) trades at USD 2.21 after a 4.19% session gain, with 22.72% over 1 week and 52.34% over 1 month, ranking sixteenth on a published one-month small cap screener snapshot.
  • Third-quarter 2026 adjusted diluted EPS was USD 0.21 against USD 0.18 a year earlier, up 16.7%, while Revenue from continuing operations fell 9.2% to USD 481.6 million.
  • Full-year 2026 guidance sets revenue at USD 1.965 billion to USD 1.985 billion, adjusted EBITDA at USD 865 million to USD 885 million and free Cash Flow at USD 320 million to USD 340 million.
  • Despite the rebound, the stock is down 21.11% over 6 months and 34.45% year to date, and total Debt of USD 4,176.1 million is large next to the small cap bucket of 300 million to 2 billion USD.

What Moved Clarivate (52% in a Month)

Clarivate (NYSE:CLVT) closed the latest session at USD 2.21, up 4.19%, after gains of 22.72% over 1 week, 52.34% over 1 month and 18.12% over 3 months in a published screener snapshot taken November 5, 2026. The company released third-quarter results on November 3, 2026, a Tuesday, and the weekly gain spans that date. Adjusted diluted EPS was USD 0.21 against USD 0.18 a year earlier, a rise of 16.7%. Adjusted Net Income reached USD 136.0 million, up 14.0% from USD 119.3 million. Adjusted EBITDA from continuing operations was USD 218.2 million, down 1.8%, and free cash flow was USD 110.2 million against USD 115.5 million. The GAAP net loss widened to USD 80.8 million, or USD 0.13 a share, from USD 28.3 million. Over nine months, adjusted EPS was USD 0.59, up 20.4%.

Why a Stock Like Clarivate Re-Rates After a Drawdown

The release does not quote earlier guidance ranges, so a guidance raise cannot be confirmed here. What it does show is a profit line that grew while sales shrank, which suits a low-base rebound after a long drawdown. Management guided 2026 adjusted diluted EPS to USD 0.73 to USD 0.77 and fourth-quarter EPS to USD 0.14 to USD 0.18. Fourth-quarter revenue is guided at USD 490 million to USD 510 million, with adjusted EBITDA Margin of 44.0% to 46.0%. Annual contract value grew 3.6% in total and 1.8% organically. As general context, sector rotation, short covering and a results beat on adjusted EPS often drive such moves, and no single catalyst beyond the results has been identified.

Valuation, Liquidity and Risks After a 52% Run

At USD 2.21 the stock sits in the small cap bucket, and a small number of trades can move the price while spreads can be wide. The 1M gain of 52.34% follows a 6M loss of 21.11% and a YTD loss of 34.45%, so the stock remains well below where it began 2026. Total debt was USD 4,176.1 million, down USD 293.8 million from the prior year-end, against cash of USD 257.0 million. Buybacks were USD 18.1 million in nine months, against USD 149.5 million a year earlier. Total revenue including divested units fell 5.3% to USD 1,740.7 million over nine months. A leveraged Balance Sheet magnifies swings in the share price, and the rebound can reverse. 52-week range and average Volume were not verified.

Where Things Stand

The stock rose because of a results-led rebound after a deep drawdown, but no single catalyst beyond the November 3, 2026 release has been identified. Clarivate (NYSE:CLVT) appears among the best small cap performers of the past month, ranking sixteenth in the snapshot's one-month list at USD 2.21. Adjusted EPS of USD 0.21 beat the year-ago USD 0.18, yet continuing revenue fell 9.2% and debt remains USD 4,176.1 million. Thin trading and wide spreads mean the move may reverse, and nothing here suggests it will continue.